9:00 – 9:30

Opening

Víctor Pérez

9:30 – 9:45

Mathematical modelling of CAR-T therapies in Gliomas

Juan Belmonte

9:45 - 10:00

Phenotypic drivers of tumor surface regularity: a computational analysis.

Juan Jiménez

10:00 – 10:15

A mathematical model for combined treatment of CAR-T cells and chemotherapy for malignant gliomas.

Matteo Italia

10:15 – 10:30

Glioblastoma Resistance Dynamics: Insights from a PDE Model of Nestin Expression

José Antonio Romero

10:30 – 10:45

Optimizing combined therapies for gliomas using in-silico patients.

Miguel Perales

10:45 – 11:00

Supporting mathematical research on brain metastases: Datasets with MRI and clinical data.

Yahir Calderón

11:00 – 11:15

Celyvir Under the Mathematical Lens: Modeling a Promising Treatment.

José García

COFFEE BREAK

12:00 – 12:15

The potential of mathematics in theranostics.

Silvia Bordel

12:15 – 12:30

Computational models of radiopharmaceutical therapy.

Jesús Bosque

12:30 – 12:45

Irregular highly metabolically active lesions correlate with early progression in b-cell lymphoma patients treated with CAR-T cells.

Soukaina Sabir

12:45 – 13:00

Individual patient dynamics of CAR-T therapy in lymphoma: Model selection and response prediction.

Álvaro Martínez

13:00 – 13:15

UMAP in Flow Cytometry in ALL.

Ana Niño

13:15 – 13:30

Application of topology and artificial intelligence in the classification of relapses in ALL.

Rocío Picón

13:30 – 13:45

Works in Progress: CAR-T in B-ALL, Topological Analysis in T-ALL, Gestational Diabetes.

María Rosa & Salvador Chulián

LUNCH BREAK

15:00 – 15:15

Pancreatic cancer

Gabriel Fernández

15:15 – 15:30

Diagnosis from UMAP based on kernel density estimation

David G. Aragonés

15:30 – 15:45

ReBOMiDe project and mathematical model for CAR-T therapy in acute lymphoblastic leukaemia.

Sergio J. Pérez

15:45 – 16:00

Predicting Denosumab Response in Fibrous Dysplasia Using PET Imaging.

Mariia Soloviova

16:00 – 16:15

Treatment optimization in Fibrous Dysplasia.

Magdalena Caballero